243 related articles for article (PubMed ID: 23342748)
21. Penicillamine-related lichenoid dermatitis and utility of zinc acetate in a Wilson disease patient with hepatic presentation, anxiety and SPECT abnormalities.
Leggio L; Ferrulli A; Mirijello A; Abenavoli L; Di Giuda D; Funiciello S; Rotoli M; Gasbarrini G; Addolorato G
Int J Immunopathol Pharmacol; 2007; 20(1):185-90. PubMed ID: 17346443
[TBL] [Abstract][Full Text] [Related]
22. [Nephrotic syndrome secondary to d-penicillamine in a patient with Wilson's disease].
Castellví Suaña JM; Xiol Quingles X; Castellote Alonso J; Guardiola Capón J
Rev Clin Esp; 1993 Oct; 193(6):343-4. PubMed ID: 8259463
[No Abstract] [Full Text] [Related]
23. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
24. [Penicillamine and other therapeutic methods in the treatment of Wilson's disease].
Czlonkowska A; Czlonkowski A
Neurol Neurochir Pol; 1975; 9(3):401-6. PubMed ID: 1097955
[No Abstract] [Full Text] [Related]
25. [Pregnancy, labor and early puerperium in a patient with Wilson's disease].
Hlinst'ák K; Borovský M; Hlinst'áková S
Ceska Gynekol; 1999 Jun; 64(3):198-200. PubMed ID: 10568054
[TBL] [Abstract][Full Text] [Related]
26. Patient with late-onset Wilson's disease: deterioration with penicillamine.
Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
[No Abstract] [Full Text] [Related]
27. D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease.
Lee Y; Lee ST; Cho H
Clin Nephrol; 2016 May; 85(5):296-300. PubMed ID: 26784915
[TBL] [Abstract][Full Text] [Related]
28. Combination treatment with penicillamine and trientine in a patient with Wilson's disease.
Kobayashi S; Kodama H; Inuzuka R; Mori Y; Yanagawa Y
Pediatr Int; 2005 Oct; 47(5):589-91. PubMed ID: 16190972
[No Abstract] [Full Text] [Related]
29. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
[TBL] [Abstract][Full Text] [Related]
30. Potential hepatotoxicity of penicillamine treatment in three patients with Wilson's disease.
Deutscher J; Kiess W; Scheerschmidt G; Willgerodt H
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):628. PubMed ID: 10554138
[No Abstract] [Full Text] [Related]
31. Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.
Chen Y; Qiu Y; Chen M; Jiang Y; Qiu X; Gao L
Australas J Dermatol; 2023 Feb; 64(1):126-130. PubMed ID: 36565232
[TBL] [Abstract][Full Text] [Related]
32. Penicillamine should not be used as initial therapy in Wilson's disease.
Brewer GJ
Mov Disord; 1999 Jul; 14(4):551-4. PubMed ID: 10435490
[No Abstract] [Full Text] [Related]
33. [2 cases of verruciform perforating elastoma after prolonged administration of D-penicillamine in Wilson's disease].
Sfar Z; Lakhoua H; Hafsia M; Amor RB; Mahfoudh H; Hamza B; Abdallah CB
Tunis Med; 1977; 55(3):167-8. PubMed ID: 919044
[No Abstract] [Full Text] [Related]
34. [Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
Li M; Zhang YH; Qin J
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):119-22. PubMed ID: 14759316
[TBL] [Abstract][Full Text] [Related]
35. Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?
Dell'era L; Boati E; Nebbia G; Corona F
Minerva Pediatr; 2012 Feb; 64(1):55-7. PubMed ID: 22350045
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
37. Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Zhu XQ; Li LY; Yang WM; Wang Y
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32809015
[TBL] [Abstract][Full Text] [Related]
38. Penicillamine: the treatment of first choice for patients with Wilson's disease.
Walshe JM
Mov Disord; 1999 Jul; 14(4):545-50. PubMed ID: 10435489
[No Abstract] [Full Text] [Related]
39. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine.
Bécuwe C; Dalle S; Ronger-Savlé S; Skowron F; Balme B; Kanitakis J; Thomas L
Dermatology; 2005; 210(1):60-3. PubMed ID: 15604549
[TBL] [Abstract][Full Text] [Related]
40. [Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
Hilz MJ; Druschky KF; Bauer J; Neundörfer B; Schuierer G
Dtsch Med Wochenschr; 1990 Jan; 115(3):93-7. PubMed ID: 2298126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
